Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ekso Bionics Holdings Inc (EKSO)

Ekso Bionics Holdings Inc (EKSO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 41,935
  • Shares Outstanding, K 8,271
  • Annual Sales, $ 13,920 K
  • Annual Income, $ -12,130 K
  • 60-Month Beta 2.09
  • Price/Sales 3.15
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.40
  • Number of Estimates 1
  • High Estimate -0.40
  • Low Estimate -0.40
  • Prior Year -0.90
  • Growth Rate Est. (year over year) +55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.18 +21.29%
on 09/08/20
5.69 -10.90%
on 08/20/20
-0.42 (-7.65%)
since 08/18/20
3-Month
3.05 +66.23%
on 06/24/20
10.74 -52.79%
on 06/26/20
+1.65 (+48.25%)
since 06/18/20
52-Week
2.25 +125.33%
on 03/27/20
11.78 -56.94%
on 10/28/19
-2.88 (-36.23%)
since 09/18/19

Most Recent Stories

More News
Medical Robotic Systems Market to Expand at 21.5% CAGR and Reach USD 10,710.6 Million; Rising Cases of Neurological Disorders to Propel Growth, says Fortune Business Insights

According to the report, the medical robotics systems market is presumed to witness an exponential CAGR of 21.5%. The market for medical robotics systems, which was valued at US$ 2,257.8 Mn in 2018 is...

CYBQF : 4.2500 (+11.84%)
EKSO : 5.07 (-4.34%)
ISRG : 655.57 (-3.72%)
MDT : 107.60 (-0.19%)
SNN : 39.31 (-2.48%)
Ekso Bionics to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 16, 2020

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer of Ekso Bionics, will present...

EKSO : 5.07 (-4.34%)
Ekso Bionics(R) Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today unveiled EVO, an endurance-boosting assistive upper body exoskeleton...

EKSO : 5.07 (-4.34%)
Global Smart Wearables market is expected to reach $960.97 million by 2027

, /PRNewswire/ --

AAPL : 106.84 (-3.17%)
EKSO : 5.07 (-4.34%)
FIT : 6.37 (-0.93%)
GRMN : 96.33 (-1.90%)
MDT : 107.60 (-0.19%)
MSFT : 200.39 (-1.24%)
SNE : 78.96 (+1.74%)
Ekso Bionics (EKSO) Reports Q2 Loss, Tops Revenue Estimates

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 0.00% and 22.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

EKSO : 5.07 (-4.34%)
Ekso Bionics: 2Q Earnings Snapshot

RICHMOND, Calif. (AP) _ Ekso Bionics Holdings Inc. (EKSO) on Thursday reported a loss of $11.8 million in its second quarter.

EKSO : 5.07 (-4.34%)
Thinking about buying stock in Soligenix Inc, Ekso Bionics, SINTX Technologies, AIM ImmunoTech, or Nio Inc?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNGX, EKSO, SINT, AIM, and NIO.

AIM : 2.09 (+1.46%)
EKSO : 5.07 (-4.34%)
NIO : 19.41 (+0.57%)
SNGXD : 4.1500 (-5.68%)
Thinking about buying stock in Ekso Bionics, Apple Inc, GNC Holdings, Microsoft Corp, or Aptevo Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EKSO, AAPL, GNC, MSFT, and APVO.

AAPL : 106.84 (-3.17%)
APVO : 7.80 (+0.65%)
EKSO : 5.07 (-4.34%)
GNC : 0.5500 (unch)
MSFT : 200.39 (-1.24%)
Ekso Bionics(R) Receives FDA Clearance to Market its EksoNR(TM) Robotic Exoskeleton for Use with Acquired Brain Injury Patients

Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today announced it has received 501(k) clearance from the U.S. Food...

EKSO : 5.07 (-4.34%)
What Makes Ekso Bionics (EKSO) a New Buy Stock

Ekso Bionics (EKSO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

EKSO : 5.07 (-4.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade EKSO with:

Business Summary

Ekso Bionics Holdings, Inc. is engaged in designing, developing and selling wearable robots or exoskeletons for the medical, military, industrial and consumer markets. The company's operating segment consists of Engineering Services and Medical segments. It operates primarily in North America, Western...

See More

Key Turning Points

2nd Resistance Point 5.56
1st Resistance Point 5.31
Last Price 5.07
1st Support Level 4.94
2nd Support Level 4.82

See More

52-Week High 11.78
Fibonacci 61.8% 8.14
Fibonacci 50% 7.01
Fibonacci 38.2% 5.89
Last Price 5.07
52-Week Low 2.25

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar